In two words ... perplexed and diasspointed.I just re-read the...

In two words ... perplexed and diasspointed.

I just re-read the 18 August 2022 Price Sensitive ASX release detailing PTX's agreement with TF for scalelable OmniCAR. Also PS releases on 16 and 23 August of the same year.

..... and the 23 August 2022 PTX presentation.

As I've mentioned before, is the Media Team in stealth mode?

I have no doubt that there are significant scientific developments taking place and the PTX/TF presentation today helps communicate that to the broader scientific community and will hopefully lead to further advances. PTX staff are doing a good job in sharing their enthusiasm for the science.

However, the conveying of information to SHs ard the investment community generally seems to be limited (and yes, I understand the IP and patenting issues)

Shellbell ..... was your comment that "Next on the collab agenda is to test cytokine release and in-vivo function, test multi-arming and clinical scale development of the latter stages of the process (which can be done here in Aust)." stated today, or is that just your understanding?